Literature DB >> 21309940

Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury.

Paulo N Martins1, Sue Chang, Basant Mahadevapa, Ann-Britt Martins, Patricia Sheiner.   

Abstract

BACKGROUND: There is a general concern that aged organs are more susceptible to ischaemia. In the light of recent proposals to change the liver allocation system by expanding regional sharing, it is feared that increased cold ischaemia time of grafts from older donors may reduce graft survival. The aim of this study was to correlate donor age and the patterns of ischaemia reperfusion injury and synthetic function early after liver transplantation.
METHODS: We performed a retrospective study of first transplants using a single-centre electronic database. Patterns of liver injury (based on transaminases and post-reperfusion biopsy), synthetic function (international normalized ratio [INR]), and graft and patient survival in recipients receiving liver grafts from donors aged ≥ 65 years (group 1, n= 50) were compared with equivalent patterns in a matched cohort of recipients transplanted with grafts from donors aged <65 years (group 2, n= 50).
RESULTS: There was no significant difference in transaminase levels from day 0 to day 6 after transplantation. When groups 1 and 2 were subdivided into two subgroups based on the duration of graft cold ischaemia time (<8 h and ≥ 8 h), there was no statistical difference in transaminase levels during the first 7 days. There were two cases (4%) of primary non-function in group 1 and one (2%) in group 2. Initial poor function did not differ significantly between the groups (26% vs. 24%; P= 0.81). In addition, there was no difference in histological changes in post-reperfusion biopsies (21% vs. 34%; P= 0.078) and rate of acute rejection episodes in the first year (30% vs. 32%; P= 0.99). There was no significant difference between groups 1 and 2 in 1-year patient and graft survivals (78% vs. 90% [P= 0.17]; 88% vs. 94% [P= 0.48], respectively).
CONCLUSIONS: Judiciously selected livers from aged donors are not associated with major increased susceptibility to ischaemia reperfusion injury.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21309940      PMCID: PMC3048974          DOI: 10.1111/j.1477-2574.2010.00275.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  55 in total

Review 1.  Immunological tolerance--the liver effect.

Authors:  R Y Calne
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

Review 2.  Heat shock response and ageing: mechanisms and applications.

Authors:  P Verbeke; J Fonager; B F Clark; S I Rattan
Journal:  Cell Biol Int       Date:  2001       Impact factor: 3.612

3.  A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors.

Authors:  Koray Tekin; Charles J Imber; Mesut Atli; Bridget K Gunson; Simon R Bramhall; David Mayer; John A C Buckels; Paul McMaster; Darius F Mirza
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

Review 4.  Aging and the liver.

Authors:  H Popper
Journal:  Prog Liver Dis       Date:  1986

5.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

Authors:  U Klotz; G R Avant; A Hoyumpa; S Schenker; G R Wilkinson
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

6.  Contribution of prolonged ischemia and donor age to chronic renal allograft dysfunction.

Authors:  Stefan Günther Tullius; Anja Reutzel-Selke; Frank Egermann; Melina Nieminen-Kelhä; Sven Jonas; Wolf Otto Bechstein; Hans-Dieter Volk; Peter Neuhaus
Journal:  J Am Soc Nephrol       Date:  2000-07       Impact factor: 10.121

7.  Analysis of donor criteria for the prediction of outcome in clinical liver transplantation.

Authors:  L Makowka; R D Gordon; S Todo; N Ohkohchi; J W Marsh; A G Tzakis; H Yokoi; J Ligush; C O Esquivel; M Satake
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

8.  Liver transplantation using organs from donors older than 60 years.

Authors:  Michael Neipp; Hueseyin Bektas; Rainer Lueck; Dilek Ceylan; Thomas Becker; Juergen Klempnauer; Bjoern Nashan
Journal:  Transpl Int       Date:  2004-08-25       Impact factor: 3.782

9.  Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance.

Authors:  M Schnegg; B H Lauterburg
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

10.  Use of elderly donors (> 60 years) for liver transplantation.

Authors:  Yi Zhao; Chung Mau Lo; Chi Leung Liu; Sheung Tat Fan
Journal:  Asian J Surg       Date:  2004-04       Impact factor: 2.767

View more
  7 in total

Review 1.  Using old liver grafts for liver transplantation: where are the limits?

Authors:  Carlos Jiménez-Romero; Oscar Caso Maestro; Félix Cambra Molero; Iago Justo Alonso; Cristina Alegre Torrado; Alejandro Manrique Municio; Jorge Calvo Pulido; Carmelo Loinaz Segurola; Enrique Moreno González
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Octogenarian liver grafts: Is their use for transplant currently justified?

Authors:  Carlos Jiménez-Romero; Felix Cambra; Oscar Caso; Alejandro Manrique; Jorge Calvo; Alejandro Marcacuzco; Paula Rioja; David Lora; Iago Justo
Journal:  World J Gastroenterol       Date:  2017-05-07       Impact factor: 5.742

3.  Protective Effects of Apoptosis of Kupffer Cells Induced by Zoledronate Liposomes Following Hepatic Ischemia-Reperfusion Injury.

Authors:  Qiao-Hong Zhao; Feng Han; Kun Wu; Jie Zhang; Tian-Fang Xia; Jian Chen; Zhen-Shen Qing; Li-Qun Pang
Journal:  Ann Transplant       Date:  2018-11-23       Impact factor: 1.530

Review 4.  An Update on Usage of High-Risk Donors in Liver Transplantation.

Authors:  Haris Muhammad; Duha Zaffar; Aniqa Tehreem; Peng-Sheng Ting; Cem Simsek; Ilker Turan; Saleh Alqahtani; Behnam Saberi; Ahmet Gurakar
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

Review 5.  Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain?

Authors:  Jeannette Widmer; Janina Eden; Mauricio Flores Carvalho; Philipp Dutkowski; Andrea Schlegel
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

6.  Predictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction.

Authors:  Jose Iglesias; Elliot Frank; Sushil Mehandru; John M Davis; Jerrold S Levine
Journal:  BMC Nephrol       Date:  2013-07-13       Impact factor: 2.388

Review 7.  The Human Immune Response to Cadaveric and Living Donor Liver Allografts.

Authors:  Angus Hann; Daniel-Clement Osei-Bordom; Desley A H Neil; Vincenzo Ronca; Suz Warner; M Thamara P R Perera
Journal:  Front Immunol       Date:  2020-06-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.